Announcements

Natalie Ashley, who began as a patient navigator with the DCBSM, has been instrumental in growing the program, say center leaders.

Medical oncologist Edwin P. Alyea, III, MD, formerly with Dana-Farber Cancer Institute, has been named chief medical officer (CMO) for Duke Cancer Institute.

Steven Bender, MBA, FHFMA, assumes his new role as director of finance, DCI, today, January 6.

Mark Oldham, PhD, has been named director of the Medical Physics Program, effective January 1, 2020.

Scott Floyd, MD, PhD, has joined the Duke Center for Brain and Spine Metastasis at DCI as associate radiation director.

Jennifer K. Plichta, MD, Assistant Professor of Surgery, Division of Surgical Oncology, on being appointed to the editorial board of Breast Cancer Research.

April Salama, MD, director of the Melanoma Disease Group, has joined the Duke Center for Brain and Spine Metastasis at DCI as associate medical director.

Duke Cancer Institute-branded merchandise is now for sale at the Belk Boutique at Duke Cancer Center Durham, at Duke Raleigh Cancer Center and at Duke Women's Cancer Care Raleigh.

Three DCI employees — from Duke Cancer Center Durham, Duke Cancer Center North Durham, and Duke Cancer Center Raleigh — were recently honored with DCI Superstar awards.